A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge

Overview of attention for article published in Science Translational Medicine, July 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Dimensions has found 81 publications that cite this research output.

Article in Cellular & Molecular Immunology (March 2024)

Article in Microorganisms (January 2024)

Article in Current Opinion in HIV and AIDS (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.